HERDOO2 risk score: ... points
HERDOO2 risk score: points
Outcome stratification
Conditional information
Result interpretation
Interpretation of results:
- In a study by Rodger et al (2008) including 646 patients with a first unprovoked venous thromboembolism (VTE) event, an annual risk of VTE recurrence of 9.3% [95% confidence interval (CI) 7.7–11.3%) was recorded in the whole cohort, and of 13.7% in men.
- On the basis of these results, the authors recommend a long-term anticoagulant treatment as always indicated for all men.
- Women with a total risk score of 0 to 1 had an annual risk of recurrence of 1.6% (95% CI 0.3-4.6%), whereas those who had a score of 2 or more had an annual risk of 14.1% (95% CI 10.9–17.3%) and deserved, according to the authors, an indefinite anticoagulation.
Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.
Model feedback
No feedback yet 1 Comment {{ model.comments.length }} Comments
Please sign in to enable Evidencio print features
If you don't have an Evidencio Community Account you can create your free personal account at:
https://www.evidencio.com/registration
Printed results - Examples {{ new Date().toLocaleString() }}

Evidencio Community Account Benefits
With an Evidencio Community account you can:
- Create and publish your own prediction models.
- Share your prediction models with your colleagues, research group, organization or the world.
- Review and provide feedback on models that have been shared with you.
- Validate your models and validate models from other users.
- Find models based on Title, Keyword, Author, Institute, or MeSH classification.
- Use and save prediction models and their data.
- Use patient specific protocols and guidelines based on sequential models and decision trees.
- Stay up-to-date with new models in your field as they are published.
- Create your own lists of favorite models and topics.
A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.
{{ variable.title }}
{{ row }} |